|
Type |
calcium antagonist |
|
Other name |
5-Isopropyl-3-methyl 2-cyano-1, 4-dihydro-6-methyl-4-(3-nitrophenyl)-3, 5-pyridinedicarboxylate |
|
Molecular formula |
C19H19N3O6 |
|
Molecular weight |
385.38 |
|
CAS |
75530-68-6 |
|
Melting point |
145-152oC |
|
Application |
This product can be used in the prevention and curing of angina, high blood pressure, cerebral vasospasm and ischemic heart disease. |
|
Draff |
More than 0.5% |
|
Loss |
More than 0.5% |
|
impurity |
Less than 1.0% |
The following is our main product list:
| NO. | English name | Molecular formula | CAS No |
| 1 | Quetiapine Fumarate | 2(C21H25N3O2S).C4H4O4 | 111974-72-2 |
| 2 | Nilvadipine | C19H19N3O6 | 75530-68-6 |
| 3 | (R)-3-Chloro-1,2-propanediol | C3H7ClO2 | 57090-45-6 |
| 4 | 3-Chloro-1,2-propanediol | C3H7ClO2 | 96-24-2 |
| 5 | 3-Tert-butylamino-1, 2-propanediol | C7H17NO2 | 30315-46-9 |
| 6 | 17-Methyltestosterone | C20H30O2 | 58-18-4 |
| 7 | Thymidine | C10H14N2O5 | 50-89-5 |
| 8 | 1-hydroxyethylethoxypiperazin | C8H18N2O2 | 13349-82-1 |
| 9 | Piperazine 68% | C4H10N2 | 110-85-0 |
| 10 | Piperazine 99.5% | C4H10N2 | 110-85-0 |
| 11 | 1-hydroxyethylethoxypiperazinedihydrochloride | C8H18N2O2.2(HCl) | 85293-16-9 |
| 12 | 11-(1-Piperazinyl)-dibenzo[b,f][1,4]thiazepine dihydrochloride | C17H17N3S.2HCl | 111974-74-4 |
| 13 | 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine | C13H9NOS | 3159-7-7 |
| 14 | 2-(2-Chloroethoxy)ethanol | C4H9ClO2 | 628-89-7 |
| 15 | 5-Isopropyl-3-methyl2-formyl-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate | C19H20N2O7 | 75530-60-8 |
| 16 | (R)-3-Amino-1, 2-propanediol | C3H9NO2 | 66211-46-9 |
| 17 | palmatine | C21H22NO4 | 3486-67-7 |
| 18 | Amlodipine Maleata | C24H29C1N2O9 | 88150-47-4 |
| 19 | Pd/C catalyst (Pd/C) | Pd/C | 7440-05-3 |
| 20 | Ru/C catalyst(Ru/C) | Ru/C | 7440-18-8 |
| 21 | Rh/C catalyst (Rh/C) | Rh/C | 7440-16-6 |
| 22 | Pt/C catalyst (Pt/C) | Pt/C | 7440-06-4 |
| 23 | Rhodium 5% on alumina | Rh | 7440-16-6 |